跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABIRATERONA MYLAN 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ABIRATERONA MYLAN 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ABIRATERONA MYLAN 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Mylan Ireland Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 3, 2022
Approval ID
6f4313bedd5ba163
Company
Mylan Ireland Limited
Type
Standard
Approval Details
Approval Id
6f4313bedd5ba163
Drug Cima Aemps Name
ABIRATERONA MYLAN 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1211571016
Holder Company Name
Mylan Ireland Limited
Marketing Company Name
Viatris Pharmaceuticals S.L.
Holder Company Detail Path
/organization/mylan-ireland-limited
Authorization Date
2022-03-03
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
1000 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Mylan Ireland Limited
Company Detail Path
/organization/mylan-ireland-limited
Company Information
Pharmaceutical Company Name
MYLAN IRELAND LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
Legal Department
Website
http://www.mylan.ie
Active Ingredients
ABIRATERONA ACETATO
1000 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 3, 2022
Approval ID
6f4313bedd5ba163
Type
Standard
Back to CIMA-AEMPS Approvals